U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07640997) titled 'Real-world Study of Aflibercept 8 mg in nAMD' on Dec. 08, 2025.
Brief Summary: The goal of this observational study is to explore the effectiveness of aflibercept 8 mg in treating both treatment-naive and previously treated patients with neovascular age-related macular degeneration (nAMD) in a real-world setting. The main questions it aims to answer are:
What are the short-term and long-term efficacy outcomes of aflibercept 8 mg in treatment-naive or previously treated nAMD patients? What are the safety characteristics and the treatment patterns of aflibercept 8 mg in these patient populations?
Participants will:
Receive afliberc...